Anemia, intractable vomiting, chronic diarrhea, and syndrome of inappropriate antidiuretic secretion: A diagnostic dilemma

Medicine (United States)

Volumn 96, Issue 52, 2017, Pages

  Tariq, Hassan ^a   Kamal, Muhammad Umar ^a   Reddy, Pavithra ^a   Bajantri, Bharat ^a   Niazi, Masooma ^a   Matela, Ajsza ^a   Zeana, Cosmina ^a   Ihimoyan, Ariyo ^a   Dev, Anil ^a   Chilimuri, Sridhar ^a  

^a BRONX LEBANON HOSPITAL CENTER   (United States)

Author keywords

Disseminated strongyloidosis; Human T lymphotropic virus; Hyperinfection syndrome; Syndrome of inappropriate antidiuretic secretion

Indexed keywords

ANTIEMETIC AGENT; CIPROFLOXACIN; IVERMECTIN; METRONIDAZOLE; SODIUM CHLORIDE;

ABDOMINAL PAIN; ADULT; ANEMIA; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CHRONIC DIARRHEA; CLINICAL ARTICLE; DISEASE ASSOCIATION; DIZZINESS; HEADACHE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; INTESTINE BIOPSY; INTESTINE LYMPHANGIECTASIA; LOSS OF APPETITE; MALE; NAUSEA; PRIORITY JOURNAL; SEROLOGY; SMALL INTESTINE OBSTRUCTION; STOMACH BIOPSY; STRONGYLOIDIASIS; SUBCLINICAL HYPERTHYROIDISM; VOMITING; WATER DEPRIVATION; WEIGHT REDUCTION; X-RAY COMPUTED TOMOGRAPHY; ANIMAL; COMPLICATION; DIARRHEA; HTLV-1 INFECTION; STRONGYLOIDES STERCORALIS;

ADULT; ANEMIA; ANIMALS; DIARRHEA; HTLV-I INFECTIONS; HUMANS; INAPPROPRIATE ADH SYNDROME; MALE; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; VOMITING;

EID: 85039419829     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000009229     Document Type: Article

References (66)

1. http://www.cdc.gov/parasites/strongyloides/health-professionals/2016.
2. Dawson-Hahn EE, Greenberg SL, Domachowske JB, et al. Eosinophilia and the seroprevalence of schistosomiasis and strongyloidiasis in newly arrived pediatric refugees: an examination of Centers for Disease Control and Prevention screening guidelines. J Pediatr 2010;156:1016-8.
3. Gill GV, Welch E, Bailey JW, et al. Chronic Strongyloides stercoralis infection in former British Far East prisoners of war. QJM 2004;97:789-95.
4. Liu LX, Weller PF. Strongyloidiasis and other intestinal nematode infections. Infect Dis Clin North Am 1993;7:655-82.
5. Nuesch R, Zimmerli L, Stockli R, et al. Imported strongyloidosis: a longitudinal analysis of 31 cases. J Travel Med 2005;12:80-4.
6. Segarra-Newnham M. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection. Ann Pharmacother 2007;41:1992-2001.
7. Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 2001;33:1040-7.
8. Concha R, Harrington WJr, Rogers AI. Intestinal strongyloidiasis: recognition, management, and determinants of outcome. J Clin Gastroenterol 2005;39:203-11.
9. Montes M, Sawhney C, Barros N. Strongyloides stercoralis: there but not seen. Curr Opin Infect Dis 2010;23:500-4.
10. Porto AF, Neva FA, Bittencourt H, et al. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. Parasite Immunol 2001;23:503-7.
11. Iriemenam NC, Sanyaolu AO, Oyibo WA, et al. Strongyloides stercoralis and the immune response. Parasitol Int 2010;59:9-14.
12. Montes M, Sanchez C, Verdonck K, et al. Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen. PLoS Negl Trop Dis 2009;3:e456.
13. Siegel MO, Simon GL. Is human immunodeficiency virus infection a risk factor for Strongyloides stercoralis hyperinfection and dissemination. PLoS Negl Trop Dis 2012;6:e1581.
14. Weatherhead JE, Mejia R. Immune Response to Infection with Strongyloides stercoralis in Patients with Infection and Hyperinfection. Curr Trop Med Rep 2014;1:229-33.
15. Ramanathan R, Nutman T. Strongyloides stercoralis infection in the immunocompromised host. Curr Infect Dis Rep 2008;10:105-10.
16. Nabha L, Krishnan S, Ramanathan R, et al. Prevalence of Strongyloides stercoralis in an urban US AIDS cohort. Pathog Glob Health 2012;106:238-44.
17. Le M, Ravin K, Hasan A, et al. Single donor-derived strongyloidiasis in three solid organ transplant recipients: case series and review of the literature. Am J Transplant 2014;14:1199-206.
18. Carvalho EM, Andrade TM, Andrade JA, et al. Immunological features in different clinical forms of strongyloidiasis. Trans R Soc TropMed Hyg 1983;77:346-9.
19. Herbert DR, Nolan TJ, Schad GA, et al. The role of B cells in immunity against larval Strongyloides stercoralis in mice. Parasite Immunol 2002;24:95-101.
20. Mahmoud AA. Strongyloidiasis. Clin Infect Dis 1996;23:949-52.
21. Galimberti R, Ponton A, Zaputovich FA, et al. Disseminated strongyloidiasis in immunocompromised patients-report of three cases. Int J Dermatol 2009;48:975-8.
22. Ganesh S, Cruz RJJr. Strongyloidiasis: a multifaceted disease. Gastroenterol Hepatol (N Y) 2011;7:194-6.
23. SatohM, Toma H, Kiyuna S, et al. Association of a sex-related difference of Strongyloides stercoralis-specific IgG4 antibody titer with the efficacy of treatment of strongyloidiasis. Am J Trop Med Hyg 2004;71:107-11.
24. Padigel UM, Lee JJ, Nolan TJ, et al. Eosinophils can function as antigenpresenting cells to induce primary and secondary immune responses to Strongyloides stercoralis. Infect Immun 2006;74:3232-8.
25. Padigel UM, Hess JA, Lee JJ, et al. Eosinophils act as antigen-presenting cells to induce immunity to Strongyloides stercoralis in mice. J Infect Dis 2007;196:1844-51.
26. Shi H-Z. Eosinophils function as antigen-presenting cells. J Leukoc Biol 2004;76:520-7.
27. Somin M, Neogolani V, Zimhony O, et al. Fatal recurrent bacterial meningitis: a complication of chronic Strongyloides infection. Eur J Intern Med 2008;19:e42-3.
28. Link K, Orenstein R. Bacterial complications of strongyloidiasis: Streptococcus bovis meningitis. South Med J 1999;92:728-31.
29. Yoshida H, Endo H, Tanaka S, et al. Recurrent paralytic ileus associated with strongyloidiasis in a patient with systemic lupus erythematosus. Mod Rheumatol 2006;16:44-7.
30. Nakada K, Kohakura M, Komoda H, et al. High incidence of HTLV antibody in carriers of Strongyloides stercoralis. Lancet 1984;1:633.
31. Hirata T, Uchima N, Kishimoto K, et al. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection. Am J Trop Med Hyg 2006;74:246-9.
32. Neva FA, Oliveira Filho J, Gam AA, et al. Interferon-g and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type I and Strongyloides stercoralis. J Infect Dis 1998;178:1856-9.
33. Evering T, Weiss L. The immunology of parasite infections in immunocompromised hosts. Parasite Immunol 2006;28:549-65.
34. Carvalho Filho EMd, Porto MAdF. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis. 2004.
35. Loutfy MR, WilsonM, Keystone JS, et al. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg 2002;66:749-52.
36. Wagenvoort J, Houben H, Boonstra G, et al. Pulmonary superinfection withStrongyloides stercoralis in an immunocompromised retired coal miner. Eur J Clin Microbiol Infect Dis 1994;13:518-9.
37. Nolan TJ, Bhopale VM, Rotman HL, et al. Strongyloides stercoralis: high worm population density leads to autoinfection in the jird (Meriones unguiculatus). Exp Parasitol 2002;100:173-8.
38. Rivero F, Kremer L, Allende L, et al. [Strongyloides stercoralis andHIV: a case report of an indigenous disseminated infection from non-endemic area]. Rev Argent Microbiol 2005;38:137-9.
39. Sato Y, Kobayashi J, Toma H, et al. Efficacy of stool examination for detection of Strongyloides infection. Am J Trop Med Hyg 1995; 53:248-50.
40. Keiser PB, Nutman TB. Strongyloides stercoralis in the Immunocompromised Population. Clin Microbiol Rev 2004;17:208-17.
41. Sarangarajan R, Ranganathan A, Belmonte AH, et al. Strongyloides stercoralis infection in AIDS. AIDS Patient Care STDS 1997;11:407-14.
42. Ferreira MS, Nishioka Sde A, Borges AS, et al. Strongyloidiasis and infection due to human immunodeficiency virus: 25 cases at a Brazilian teaching hospital, including seven cases of hyperinfection syndrome. Clin Infect Dis 1999;28:154-5.
43. Ohnishi K, Kogure H, Kaneko S, et al. Strongyloidiasis in a patient with acquired immunodeficiency syndrome. J Infect Chemother 2004;10: 178-80.
44. Viney ME, Brown M, Omoding NE, et al. Why does HIV infection not lead to disseminated strongyloidiasis? J Infect Dis 2004;190:2175-80.
45. BrownM, Kizza M, Watera C, et al. Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda. J Infect Dis 2004;190:1869-79.
46. Hughes R, McGuire G. Delayed diagnosis of disseminated strongyloidiasis. Intensive Care Med 2001;27:310-2.
47. Pornsuriyasak P, Niticharoenpong K, Sakapibunnan A. Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: a case report of intractable strongyloidiasis. Southeast Asian J Trop Med Public Health 2004;35:531-4.
48. Reddy TS, Myers JW. Syndrome of inappropriate secretion of antidiuretic hormone and nonpalpable purpura in a woman with Strongyloides stercoralis hyperinfection. Am J Med Sci 2003; 325:288-91.
49. Seet RC, Gong LL, Tambyath PA. Image of the month. Strongyloides stercoralis hyperinfection and syndrome of inappropriate secretion of antidiuretic hormone. Gastroenterology 2005;128:252.
50. Hayashi E, Ohta N, Yamamoto H. Syndrome of inappropriate secretion of antidiuretic hormone associated with strongyloidiasis. Southeast Asian J Trop Med Public Health 2007;239-46.
51. Aregawi D, Lopez D, Wick M, et al. Disseminated strongyloidiasis complicating glioblastoma therapy: a case report. J Neurooncol 2009;94:439-43.
52. Khanna S, Sedlack RE, Mangan TF. An unusual case of SIADH. Gastroenterol Hepatol (N Y) 2011;7:191-3.
53. Chowdhury DN, Dhadham GC, Shah A, et al. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) in Strongyloides stercoralis hyperinfection. J Glob Infect Dis 2014;6:23-7.
54. Zibaei M. Whats new in global infectious diseases? Strongyloidiasis and syndrome of inappropriate antidiuretic hormone secretion (SIADH). J Glob Infect Dis 2014;6:1-2.
55. Khushman M, Morris MI, Diaz L, et al. Syndrome of inappropriate antidiuretic hormone secretion secondary to strongyloides stercoralis infection in an allogeneic stem cell transplant patient: a case report and literature review. Transplant Proc 2017;49:373-7.
56. Krolewiecki AJ, Ramanathan R, Fink V, et al. Improved diagnosis of Strongyloides stercoralis using recombinant antigen-based serologies in a community-wide study in northern Argentina. Clin Vaccine Immunol 2010;17:1624-30.
57. Sato Y, Takara M, Otsuru M. Detection of antibodies in strongyloidiasis by enzyme-linked immunosorbent assay (ELISA). Trans R Soc Trop Med Hyg 1985;79:51-5.
58. Genta RM. Predictive value of an enzyme-linked immunosorbent assay (ELISA) for the serodiagnosis of strongyloidiasis. Am J Clin Pathol 1988;89:391-4.
59. Hallsworth MP, Litchfield TM, Lee TH. Glucocorticoids inhibit granulocyte-macrophage colony-stimulating factor-1 and interleukin-5 enhanced in vitro survival of human eosinophils. Immunology 1992;75:382-5.
60. Wallen N, Kita H, Weiler D, et al. Glucocorticoids inhibit cytokinemediated eosinophil survival. J Immunol 1991;147:3490-5.
61. Datry A, Hilmarsdottir I, Mayorga-Sagastume R, et al. Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases. Trans R Soc Trop Med Hyg 1994;88:344-5.
62. Shimasaki T, Chung H, Shiiki S. Five cases of recurrent meningitis associated with chronic strongyloidiasis. Am J Trop Med Hyg 2015;92:601-4.
63. Lim S, Katz K, Krajden S, et al. Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management. CMAJ 2004;171:479-84.
64. Biggs BA, Caruana S, Mihrshahi S, et al. Management of chronic strongyloidiasis in immigrants and refugees: is serologic testing useful? Am J Trop Med Hyg 2009;80:788-91.
65. Karunajeewa H, Kelly H, Leslie D, et al. Parasite-specific IgG response and peripheral blood eosinophil count following albendazole treatment for presumed chronic strongyloidiasis. J Travel Med 2006;13:84-91.
66. Vandebosch S, Mana F, Goossens A, et al. Strongyloides Stercoralis infection associated with repititive bacterial meningitis and SIADH: a case report. Acta Gastroenterol Belg 2008;71:413-7.